There was no significant difference in gender and age between the healthy individuals and NAFLD patients, while BMI, AST, ALT, GGT and TG in NAFLD patients were significantly higher than those in healthy individuals. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.